These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24812013)

  • 21. Treatable Leigh-like encephalopathy presenting in adolescence.
    Fassone E; Wedatilake Y; DeVile CJ; Chong WK; Carr LJ; Rahman S
    BMJ Case Rep; 2013 Oct; 2013():200838. PubMed ID: 24099834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.
    Yamada K; Miura K; Hara K; Suzuki M; Nakanishi K; Kumagai T; Ishihara N; Yamada Y; Kuwano R; Tsuji S; Wakamatsu N
    BMC Med Genet; 2010 Dec; 11():171. PubMed ID: 21176162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial infantile bilateral striatal necrosis: clinical features and response to biotin treatment.
    Straussberg R; Shorer Z; Weitz R; Basel L; Kornreich L; Corie CI; Harel L; Djaldetti R; Amir J
    Neurology; 2002 Oct; 59(7):983-9. PubMed ID: 12374138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?
    Kamaşak T; Havalı C; İnce H; Eyüboğlu İ; Çebi AH; Sahin S; Cansu A; Aydin K
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1139-1149. PubMed ID: 30054086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone.
    Tabarki B; Alfadhel M; AlShahwan S; Hundallah K; AlShafi S; AlHashem A
    Eur J Paediatr Neurol; 2015 Sep; 19(5):547-52. PubMed ID: 26095097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.
    Serrano M; Rebollo M; Depienne C; Rastetter A; Fernández-Álvarez E; Muchart J; Martorell L; Artuch R; Obeso JA; Pérez-Dueñas B
    Mov Disord; 2012 Sep; 27(10):1295-8. PubMed ID: 22777947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease.
    Nyhan WL; McGowan K; Barshop BA
    Clin Chim Acta; 2019 Dec; 499():13-15. PubMed ID: 31404531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early treatment of biotin-thiamine-responsive basal ganglia disease improves the prognosis.
    Wesół-Kucharska D; Greczan M; Kaczor M; Pajdowska M; Piekutowska-Abramczuk D; Ciara E; Halat-Wolska P; Kowalski P; Jurkiewicz E; Rokicki D
    Mol Genet Metab Rep; 2021 Dec; 29():100801. PubMed ID: 34631424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotin-Thiamine-Responsive Basal Ganglia Disease-A Treatable Metabolic Disorder.
    Mir A; Alhazmi R; Albaradie R
    Pediatr Neurol; 2018 Oct; 87():80-81. PubMed ID: 30119991
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotin-responsive basal ganglia disease: case report and review of the literature.
    El-Hajj TI; Karam PE; Mikati MA
    Neuropediatrics; 2008 Oct; 39(5):268-71. PubMed ID: 19294600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teaching NeuroImages: MRI findings of biotin-responsive basal ganglia disease before and after treatment.
    Bin Saeedan M; Dogar MA
    Neurology; 2016 Feb; 86(7):e71-2. PubMed ID: 26880816
    [No Abstract]   [Full Text] [Related]  

  • 32. An unusually mild case of biotin-thiamine-responsive basal ganglia disease.
    Lail G; Blaser S; Inbar-Feigenberg M
    Mol Genet Metab Rep; 2023 Dec; 37():101004. PubMed ID: 38053933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of high thiamine dosage in treating patients with biotin thiamine responsive basal ganglia disease: a two case reports.
    Aldosari AN
    Int J Neurosci; 2024 May; ():1-5. PubMed ID: 38709666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease.
    Alfadhel M; Al-Bluwi A
    Child Neurol Open; 2017; 4():2329048X17730742. PubMed ID: 28944253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basal ganglia and apraxia.
    Pramstaller PP; Marsden CD
    Brain; 1996 Feb; 119 ( Pt 1)():319-40. PubMed ID: 8624692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotin-thiamine-responsive basal ganglia disease: A case report.
    Majumdar S; Salamon N
    Radiol Case Rep; 2022 Mar; 17(3):753-758. PubMed ID: 35003475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Child Neurology: Infantile Biotin Thiamine Responsive Basal Ganglia Disease: Case Report and Brief Review.
    Maney K; Pizoli C; Russ JB
    Neurology; 2023 Apr; 100(17):836-839. PubMed ID: 36657988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing.
    Kohrogi K; Imagawa E; Muto Y; Hirai K; Migita M; Mitsubuchi H; Miyake N; Matsumoto N; Nakamura K; Endo F
    J Hum Genet; 2015 Jul; 60(7):381-5. PubMed ID: 25876998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.
    Zeng WQ; Al-Yamani E; Acierno JS; Slaugenhaupt S; Gillis T; MacDonald ME; Ozand PT; Gusella JF
    Am J Hum Genet; 2005 Jul; 77(1):16-26. PubMed ID: 15871139
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.